Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients.
Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
J
J
Crocker
K
K
Renton
A
A
Wade
H
H
McLellan
P
P
Acott
D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007223:Infant; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine